Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI Trial

BACKGROUND AND OBJECTIVE: In patients with atrial fibrillation following percutaneous coronary intervention, if a proton pump inhibitor is used, could that allow the use of warfarin triple therapy, or is there additional reduction in bleeding while using it with dual therapy? METHODS: The RE-DUAL PC...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicolau, José C., Bhatt, Deepak L., Hohnloser, Stefan H., Kimura, Takeshi, Lip, Gregory Y. H., Miede, Corinna, Nordaby, Matias, Oldgren, Jonas, Steg, Philippe Gabriel, ten Berg, Jurriën M., Godoy, Lucas C., Cannon, Christopher P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320045/
https://www.ncbi.nlm.nih.gov/pubmed/32562206
http://dx.doi.org/10.1007/s40265-020-01323-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320045/
https://www.ncbi.nlm.nih.gov/pubmed/32562206
http://dx.doi.org/10.1007/s40265-020-01323-x

Ejemplares similares